2024 HY Results ENGFRNL Title Format Download Press release Excel Data XLSX Download Management Report PDF Download Presentation HY Presentation PDF Download Presentation Replay Presentation Transcript PDF Download Facts & Figures PDF Download Other documents Title Format Download Capital Market Call 30.09.2024 PDF Download Reminder document for Half-Year 2024 modelling PDF Download Capital Market Call 12.06.2024 PDF Download Scientific Presentations, Abstracts, Posters, and Publications for Shareholders, Investors, and other Capital Market Participants Only The following documents are specifically for shareholders, investors, and other capital market participants. The webpages are not intended for members of the general public. Bimekizumab Rozanolixizumab Zilucoplan Corporate Governance Documents Also find more information on the dedicated section of our website. Governance charter Dealing code Code of conduct UCB Reports Archive ENGFRNL Title Year Format Download Half-Year Report 2013 PDF Download Annual Report 2012 PDF Download Half-Year Report 2012 PDF Download Annual Report 2011 PDF Download Half-Year Report 2011 PDF Download View more Contact UCB IR Team investor-relations@ucb.com or a specific team member:Antje Witte, Head of Investor RelationsTel: +32 2 559 9414E-mail: Antje.Witte@ucb.com Sahar Yazdian, Investor Relations Lead Tel: +32 2 559 9137E-mail: Sahar.Yazdian@ucb.com Book a virtual meeting Send us feedback UCB IR App